Samsung Biologics to push CDO business as big as CMO
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
Samsung Biologics is driving efforts to attract new customers in contract development organization (CDO) business beyond mainstay contract manufacturing organization (CMO) with a focus on its operational agility and digital transformation, according to its executive on Tuesday.
The company’s fourth plant in Songdo, Incheon was built only in 23 months and became a global CMO leader in terms of production capacity.
“It took only 23 months for us to build the fourth plant. It usually takes 48 months. We also shortened the technology transfer period from 6 months to 3 months. This represents our speed and digital capabilities,” James Park, executive vice president and head of global sales center at Samsung Biologics, said during a press conference held in Frankfurt, Germany, last Tuesday.
For the fourth plant which already entered partial operation, Samsung Biologics employed what it calls the parallel construction method, which conducts external construction and internal facility work simultaneously. The company succeeded in curtailing the total construction period by 40 percent with this method.
Another competitive advantage Samsung Biologics boasts of in terms of speed is its fast production of drug substances through its proprietary cell culture technology. The company conducts cell culture and impurities removal at the same time in the stage just before the final cell culture. With this method, the company shortened the production period by up to 30 percent.
Samsung Biologics is speeding up efforts to secure global Big Pharma customers based on its CDO competitiveness. The company also highlighted digital capabilities as one of its key competitive edges. Live Virtual Tour (LVT), which was implemented for the first time in the pharmaceutical and biotech industry, is a case in point.
By Shin Yoo-kyung and Minu Kim
Copyright © 매일경제 & mk.co.kr. 무단 전재, 재배포 및 AI학습 이용 금지
- “조바심에 산 집이 독 됐다”…영끌족 성지 ‘노도강’ 속절없이 하락 - 매일경제
- 김용 기소 앞두고 野 이재명 지키기…“대장동 수사 ‘박영수 키즈’는 손 떼라” - 매일경제
- 일주일 뒤 단풍 산행 금지령? 설악산에 무슨 일이… - 매일경제
- ‘공개수배’ 전자발찌 훼손 40대 성범죄자, 하루만에 붙잡혀 - 매일경제
- 고현정, 카메라 뒤에선 장난기 가득...러블리 동안 미모
- 적색수배 윤지오 “난 공익제보자...얼마나 잘 사는지 보여줄 것” - 매일경제
- [속보] ‘서해 피격’ 서욱 前국방장관 석방…구속적부심 인용 - 매일경제
- 9월 경상수지 가까스로 흑자전환했지만…연간 흑자목표 달성 불투명 - 매일경제
- ‘비장한’ 추신수 ‘오늘 끝낸다’ [MK포토] - MK스포츠
- 中언론 “데프트, 10년의 꿈을 이룬 끈기·노력” [롤드컵] - MK스포츠